Page last updated: 2024-09-04

canertinib and Esophageal Neoplasms

canertinib has been researched along with Esophageal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ako, E; Hirakawa, K; Hori, T; Kubo, N; Ohira, M; Sawada, T; Yamashita, Y; Yamazaki, M1

Other Studies

1 other study(ies) available for canertinib and Esophageal Neoplasms

ArticleYear
The pan-erbB tyrosine kinase inhibitor CI-1033 inhibits human esophageal cancer cells in vitro and in vivo.
    Oncology reports, 2007, Volume: 17, Issue:4

    Topics: Animals; Carcinoma, Squamous Cell; Cell Proliferation; ErbB Receptors; Esophageal Neoplasms; Female; Humans; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase Kinases; Morpholines; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Xenograft Model Antitumor Assays

2007